Literature DB >> 32479159

Related molecular mechanisms of COVID-19, hypertension, and diabetes.

Erman Akkus1, Mustafa Sahin2.   

Abstract

Entities:  

Keywords:  COVID-19; diabetes; hypertension

Mesh：

Substances：

Year:  2020        PMID： 32479159      PMCID： PMC7276978          DOI： 10.1152/ajpendo.00164.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN： 0193-1849            Impact factor:   4.310


× No keyword cloud information.
  7 in total

1.  ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects.

Authors:  Shlomo Keidar; Alexander Strizevsky; Ayelet Raz; Aviva Gamliel-Lazarovich
Journal:  Nephrol Dial Transplant       Date:  2006-11-09       Impact factor: 5.992

2.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Authors:  Lei Fang; George Karakiulakis; Michael Roth
Journal:  Lancet Respir Med       Date:  2020-03-11       Impact factor: 30.700

3.  O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5.

Authors:  Qiming Wang; Peining Fang; Rui He; Mengqi Li; Haisheng Yu; Li Zhou; Yu Yi; Fubing Wang; Yuan Rong; Yi Zhang; Aidong Chen; Nanfang Peng; Yong Lin; Mengji Lu; Ying Zhu; Guoping Peng; Liqun Rao; Shi Liu
Journal:  Sci Adv       Date:  2020-04-15       Impact factor: 14.136

4.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

5.  AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Authors:  Roselle Gélinas; Florence Mailleux; Justine Dontaine; Laurent Bultot; Bénédicte Demeulder; Audrey Ginion; Evangelos P Daskalopoulos; Hrag Esfahani; Emilie Dubois-Deruy; Benjamin Lauzier; Chantal Gauthier; Aaron K Olson; Bertrand Bouchard; Christine Des Rosiers; Benoit Viollet; Kei Sakamoto; Jean-Luc Balligand; Jean-Louis Vanoverschelde; Christophe Beauloye; Sandrine Horman; Luc Bertrand
Journal:  Nat Commun       Date:  2018-01-25       Impact factor: 14.919

6.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

7.  Speculation is not evidence: antihypertensive therapy and COVID-19.

Authors:  Giovanni de Simone; Costantino Mancusi
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2020-07-01
  7 in total
  2 in total

Review 1.  The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism.

Authors:  Abdolkarim Mahrooz; Giovanna Muscogiuri; Raffaella Buzzetti; Ernesto Maddaloni
Journal:  Endocrine       Date:  2021-04-22       Impact factor: 3.633

Review 2.  Mechanisms of COVID-19 pathogenesis in diabetes.

Authors:  Chandrakala Aluganti Narasimhulu; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-07-01       Impact factor: 5.125
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.